Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Phothera® Announces 2026-2027 Scientific Advisory Board of Leading Dermatology and Phototherapy Experts

      Embrace Life with Confidence

      News provided by

      Phothera

      Nov 17, 2026, 06:00 ET

      Share this article

      Share this article


      BRYAN, Ohio, Nov. 17, 2026 /PRNewswire/ -- Phothera®, a leading manufacturer of FDA-cleared at-home and in-office phototherapy devices, bringing together the trusted phototherapy brands Daavlin and National Biological, today announced its 2026–2027 Scientific Advisory Board. The seven-member Board will provide expert clinical guidance on narrowband ultraviolet B (NB-UVB) phototherapy, physician education, research priorities, and opportunities to improve access to treatment for chronic skin conditions, including vitiligo, psoriasis, atopic dermatitis (eczema), and cutaneous T-cell lymphoma (CTCL).

      Chaired by Raja Sivamani, MD, MS, AP, Dermatologist, Pacific Skin Institute and Consultant/Acting Chief Medical Officer, Phothera, the Board brings together experts in inflammatory skin diseases, pigmentary disorders, and complex medical dermatology. Its members have held leadership positions within prominent professional organizations, academic institutions, and clinical research programs, contributing to advances in dermatologic care and phototherapy.

      "Bringing together this caliber of clinical expertise is an important milestone for Phothera," said Austin Monroe, Vice President of Marketing at Phothera. "As treatment options in dermatology continue to expand, we have an opportunity to strengthen the role of phototherapy through research, education, and closer collaboration with the physicians who use it. Access is central to that work. With access to more than 200 million covered lives, we are committed to making home phototherapy a practical option for every patient who can benefit from it."

      Meet the Phothera Scientific Advisory Board

      Board members include:

      • Raja Sivamani, MD, MS, AP: Chair and Acting Chief Medical Officer, Phothera. Board-certified dermatologist and clinical researcher with expertise in inflammatory skin diseases and dermatologic therapeutics. A longstanding clinical advisor to Phothera, Dr. Sivamani brings extensive knowledge of the company's phototherapy technology and clinical priorities. Sacramento, CA.

      • Seemal R. Desai, MD, FAAD: President of the Global Vitiligo Foundation and Past President of the American Academy of Dermatology and the Skin of Color Society, recognized internationally for his leadership in vitiligo, pigmentary disorders, and skin of color dermatology. Dallas, TX.

      • Nada Elbuluk, MD, MSc, FAAD: Professor of Clinical Dermatology at the Keck School of Medicine of USC and the Founding Director of the USC Skin of Color and Pigmentary Disorders Program. She is the Immediate Past President of the Skin of Color Society and a board member of the Global Vitiligo Foundation. She is recognized nationally and internationally for her contributions to pigmentary disorders, skin of color dermatology, health equity, and dermatologic education. Los Angeles, CA.

      • Pearl E. Grimes, MD, FAAD: Founder of the Vitiligo & Pigmentation Institute of Southern California, Clinical Professor of Dermatology at the David Geffen School of Medicine at UCLA, and Immediate Past President of the Global Vitiligo Foundation. Internationally recognized expert in vitiligo and pigmentary disorders, actively involved in home phototherapy for over 25 years, with extensive contributions to clinical research and dermatologic education. Los Angeles, CA.

      • Iltefat H. Hamzavi, MD, FAAD: Dr. Iltefat Hamzavi is a board-certified dermatologist at Henry Ford Hospital and at Hamzavi Dermatology Specialists, where his work focuses on vitiligo, photomedicine, and hidradenitis suppurativa. He is the co-founder and former president of the Global Vitiligo Foundation. He has co-authored over 300 peer-reviewed papers and has been honored by the American Academy of Dermatology with the John Kenney Lifetime Achievement Award. Detroit, MI.

      • Nicholas K. Mollanazar, MD, MBA: Assistant Professor of Clinical Dermatology and Director of Patient Access, Dermatology, at the Perelman School of Medicine at the University of Pennsylvania, with expertise in complex medical dermatology, autoimmune skin diseases, and clinical care innovation. Philadelphia, PA.

      • Eingun James Song, MD, FAAD: Chief Medical Officer and Director of Clinical Research at Frontier Dermatology, with expertise in psoriasis, atopic dermatitis, and clinical research involving inflammatory skin diseases. Mill Creek, WA.

      Advancing At-Home and In-Office NB-UVB Phototherapy

      Narrowband UVB phototherapy is an established, non-drug treatment option used in the management of several chronic skin conditions. Treatment may be delivered in a dermatology clinic or, when prescribed by a healthcare provider, through an at-home phototherapy device.

      The Scientific Advisory Board will advise Phothera on clinical research priorities, physician education, and opportunities to expand the understanding and appropriate use of NB-UVB phototherapy.

      A key focus will be the evolving role of at-home phototherapy, including its potential to reduce the treatment burden associated with frequent office visits. The Board will also explore phototherapy in combination with emerging therapies, barriers to adoption, and opportunities to advance phototherapy through clinical research, technology, and innovation.

      The Board will meet quarterly and contribute to scientific discussions, educational programs, and clinical initiatives designed to support dermatologists and improve patient care.

      About Phothera®

      Backed by over 80 years of combined expertise, Phothera is united under Madison Industries with one mission: expanding access to proven phototherapy for people living with chronic skin conditions. As a leading provider of FDA-cleared home and in-office narrowband ultraviolet B (NB-UVB) solutions, we're proud to help patients and prescribers navigate treatment through trusted technology, modern solutions, dedicated support, and a broad portfolio of targeted devices.

      www.phothera.com 

      SOURCE Phothera

      Modal title

      Also from this source

      Aetna Updates Coverage Policy to Include Home Phototherapy for Vitiligo

      Phothera announced today that Aetna has updated its coverage policy to include home phototherapy for the treatment of vitiligo, effective July 2026....

      Phothera® Supports Vitiligo Awareness Month with "Shine a Light on Vitiligo" Campaign

      Phothera® Supports Vitiligo Awareness Month with "Shine a Light on Vitiligo" Campaign

      Phothera, a leading manufacturer of FDA-cleared phototherapy devices for chronic skin conditions including vitiligo, psoriasis, atopic dermatitis,...

      More Releases From This Source

      Explore

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Biotechnology

      Biotechnology

      Health Care & Hospitals

      Health Care & Hospitals

      Education

      Education

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.